The effect of Hepar Magnesium D10 on fibromyalgia syndrome: A pilot study

摘要: Abstract Objectives : To evaluate the effect of anthroposophic drug Hepar Magnesium D10 intravenously administered weekly on fibromyalgia symptoms. Methods Forty-two patients attending their general practitioner for FM complaints were included by 18 practitioners. Patients asked to complete Fibromyalgia Impact Questionnaire (FIQ) at baseline, after five and ten weeks treatment. Forty-one completed FIQ baseline weeks. Thirty Cohen's delta sizes calculated all items. Results After weeks, nine out items demonstrated a statistically significant improvement. size was small in two items, medium seven large one item. In mean improvement least 20%. zero item, six four Total score improved 20% 41.5% 50% after, respectively. Conclusion There are clear indications that can have positive symptoms subgroup benefits from this A randomized controlled trial is indicated study effects